§ 1.833. Requirements for a "Sequence Listing XML" for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.
233 words·~1 min read·
/us/cfr/t37/s§ 1.833·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)The "Sequence Listing XML" as required by § 1.831(a) must be presented as a single file in XML 1.0 encoded using Unicode UTF-8, where the character set complies with paragraphs 40 and 41 and Annex IV of WIPO Standard ST.26 (incorporated by reference, see § 1.839).
(b)The "Sequence Listing XML" presented in accordance with paragraph
(a)of this section must further:
(1)Be valid according to the Document Type Definition
(DTD)as presented in WIPO Standard ST.26, Annex II.
(2)Comply with the requirements of WIPO Standard ST.26 to include:
(i)An XML declaration as defined in paragraph 39(a) of WIPO Standard ST.26;
(ii)A document type (DOCTYPE) declaration as defined in paragraph 39(b) of WIPO Standard ST.26;
(iii)A root element as defined in paragraph 43 of WIPO Standard ST.26;
(iv)A general information part that complies with the requirements of paragraphs 45, 47, and 48, as applicable, of WIPO Standard ST.26; and
(v)A sequence data part that complies with the requirements of paragraphs 50-55, 57, 58, 60-69, 71-78, 80-87, 89-98, and 100, as applicable, of WIPO Standard ST.26 representing the nucleotide and/or amino acid sequences according to § 1.832.
(3)Include an INSDQualifier\_\_value element with a value in English for any language-dependent free text qualifier as defined by paragraphs 76 and 85-87 of WIPO Standard ST.26, and as required by § 1.52(b)(1)(ii). \[87 FR 30818, May 20, 2022\]